Breast Cancer Research
Multiple clinical trials focusing on hormone receptor-positive and HER2-negative breast cancer treatments, evaluating innovative therapies including ribociclib and elacestrant combined with endocrine therapy.
- Early-stage breast cancer treatments
- Triple-negative breast cancer therapies
- Post-surgery treatment options
Studies aim to improve survival rates and treatment effectiveness for various breast cancer subtypes.
Blood Cancer Studies
Comprehensive research into chronic lymphocytic leukemia and lymphomas, investigating combinations of targeted therapies including venetoclax, ibrutinib, and obinutuzumab.
- Mantle cell lymphoma treatments
- Follicular lymphoma therapies
- Multiple myeloma interventions
Focus on developing more effective treatment combinations for various blood cancers.
Cardiovascular Research
Innovative trials examining treatments for atherosclerotic cardiovascular disease and stroke prevention in patients with atrial fibrillation.
- Stroke prevention therapies
- Blood clot prevention studies
- Cardiovascular disease management
Research aims to improve cardiovascular outcomes and reduce major adverse cardiac events.
